Tuberculosis Transmission in Botswana

著者: Bonora, S., Boffito, M., Audagnotto, S., Di Perri, G.
出版事項 2001

Antiretroviral therapy and cardiovascular risk

著者: Ridha, E, Devitt, E, Boffito, M, Boag, F
出版事項 2011

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers

著者: Jackson, AGA, Hill, A, Else, LJ, Back, DJ, Morley, R, Puls, R, Amin, J, Lin, E, Boffito, M
出版事項 2010

Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients

著者: Dickinson, L, Jackson, AGA, Garvey, LJ, Watson, V, Khoo, SH, Winston, A, Boffito, M, Davies, GR, Back, DJ
出版事項 2010

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV‐negative controls

著者: De Francesco, D, Underwood, J, Bagkeris, E, Boffito, M, Post, FA, Mallon, PWG, Vera, JH, Williams, I, Anderson, J, Johnson, M, Sabin, CA, Winston, A
出版年 HIV Med (2019)

Nevirapine Plasma Exposure Affects both Durability of Viral Suppression and Selection of Nevirapine Primary Resistance Mutations in a Clinical Setting

著者: González de Requena, D., Bonora, S., Garazzino, S., Sciandra, M., D'Avolio, A., Raiteri, R., Marrone, R., Boffito, M., De Rosa, F. G., Sinicco, A., Di Perri, G.
出版事項 2005

Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study

著者: Dickinson, L, Amin, J, Else, L, Boffito, M, Egan, D, Owen, A, Khoo, S, Back, D, Orrell, C, Clarke, A, Losso, M, Phanuphak, P, Carey, D, Cooper, DA, Emery, S
出版年 Clin Pharmacol Ther (2015)

High‐risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV‐positive men who have sex with men

著者: Pool, ERM, Winston, A, Bagkeris, E, Vera, JH, Mallon, PWG, Sachikonye, M, Post, FA, Pozniak, A, Boffito, M, Anderson, J, Williams, I, Johnson, M, Burgess, L, Sabin, CA
出版年 HIV Med (2018)